This is a preview of subscription content, log in via an institution to check access.
Change history
11 March 2016
Nature Reviews Drug Discovery 15, 78–79 (2016). The value of M&A deals in Q4 2015 was incorrectly stated as $689 billion. The correct value is $187 billion. The text and figure have been corrected accordingly.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary information S1 (figure)
Distribution of the 26 M&A deals in 2015 worth ≥US$1 billion by target focus. (PDF 109 kb)
Supplementary information S2 (table)
Top 15 biopharma partnerships of 2015 by total deal value* (PDF 123 kb)
Supplementary information S3 (figure)
Partnership deal activity in 2015 by phase of development. (PDF 354 kb)
PowerPoint slides
Rights and permissions
About this article
Cite this article
Micklus, A., Muntner, S. Biopharma deal-making in 2015: changing the pharma landscape. Nat Rev Drug Discov 15, 78–79 (2016). https://doi.org/10.1038/nrd.2016.10
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2016.10
- Springer Nature Limited
This article is cited by
-
Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein
Pharmaceutical Research (2017)
-
Erratum: Biopharma deal-making in 2015: changing the pharma landscape
Nature Reviews Drug Discovery (2016)